Literature DB >> 16564912

Prognostic significance of microvessel density and vascular endothelial growth factor expression in sinonasal carcinomas.

Guido Valente1, Carlo Mamo, Antonella Bena, Elisa Prudente, Cristina Cavaliere, Simonetta Kerim, Giuseppina Nicotra, Alberto Comino, Giorgio Palestro, Ciro Isidoro, Fabio Beatrice.   

Abstract

The prognostic significance of microvessel density and proliferative activity of the neoplastic cells, evaluated respectively by CD31 and Ki-67 positivity, and immunohistochemical expression of vascular endothelial growth factor (VEGF) was retrospectively investigated in 105 cases of sinonasal carcinoma (80 surgical specimens and 25 biopsies). The most represented histologic types were intestinal-type adenocarcinoma found in 36 patients (34.3%), squamous cell carcinoma (SCC) in 34 (32.4%), mucinous adenocarcinoma (mainly made up of signet-ring cell patterns) in 15 (14.3%), and adenoid cystic carcinoma in 7 (6.7%). Microvessel density values (in vessels per square millimeter), VEGF, and Ki-67 were not dependent on histologic type but were rather correlated to the histologic grading in SCC. Clinical data were available for 92 (87.6%) of 105 patients, with minimum follow-up of 48 months. Most of the patients (81.5%) were at an advanced stage (T3-T4) at diagnosis. The values of all markers were correlated to tumor stage (P = .03). Multivariate analysis showed that both microvessel density and proliferative activity of the neoplastic cells were independent prognostic parameters (mortality hazard ratio, 1.33 and 1.60, respectively). Although VEGF expression was not correlated to prognosis on the whole series (P = .06), it was a powerful prognostic marker when the analysis was restricted to the group of SCCs (hazard ratio, 3.02; 90% confidence interval, 1.58-5.80). These results show that tumor neoangiogenesis, expressed by microvessel density, together with proliferative activity, is a pathologic marker with a strong prognostic impact in sinonasal carcinomas. Therefore, it may be a useful tool in this field so as to carry out therapeutic protocol planning, which may be further enhanced by the adoption of the more recent antiangiogenic molecules.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16564912     DOI: 10.1016/j.humpath.2005.11.021

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  5 in total

1.  Standard diffusion-weighted, diffusion kurtosis and intravoxel incoherent motion MR imaging of sinonasal malignancies: correlations with Ki-67 proliferation status.

Authors:  Zebin Xiao; Yufeng Zhong; Zuohua Tang; Jinwei Qiang; Wen Qian; Rong Wang; Jie Wang; Lingjie Wu; Wenlin Tang; Zhongshuai Zhang
Journal:  Eur Radiol       Date:  2018-01-30       Impact factor: 5.315

2.  Multi-parametric MRI-based radiomics signature for preoperative prediction of Ki-67 proliferation status in sinonasal malignancies: a two-centre study.

Authors:  Shucheng Bi; Jie Li; Tongyu Wang; Fengyuan Man; Peng Zhang; Feng Hou; Hexiang Wang; Dapeng Hao
Journal:  Eur Radiol       Date:  2022-06-10       Impact factor: 7.034

3.  A Novel Platform for Immune Tolerance Induction in Hemophilia A Mice.

Authors:  Simone Merlin; Elvira Stefania Cannizzo; Ester Borroni; Valentina Bruscaggin; Piercarla Schinco; Warut Tulalamba; Marinee K Chuah; Valder R Arruda; Thierry VandenDriessche; Maria Prat; Guido Valente; Antonia Follenzi
Journal:  Mol Ther       Date:  2017-05-26       Impact factor: 11.454

4.  Three-dimensional pulsed continuous arterial spin labeling and intravoxel incoherent motion imaging of nasopharyngeal carcinoma: correlations with Ki-67 proliferation status.

Authors:  Wenxiu Wu; Guihua Jiang; Zhifeng Xu; Ruoning Wang; Aizhen Pan; Mingyong Gao; Tian Yu; Linwen Huang; Qiang Quan; Jin Li
Journal:  Quant Imaging Med Surg       Date:  2021-04

5.  Dual-energy CT in differentiating benign sinonasal lesions from malignant ones: comparison with simulated single-energy CT, conventional MRI, and DWI.

Authors:  Peng Wang; Zuohua Tang; Zebin Xiao; Rujian Hong; Rong Wang; Yuzhe Wang; Yang Zhan
Journal:  Eur Radiol       Date:  2021-08-24       Impact factor: 5.315

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.